Henriques, S.C.; Paixão, P.; Almeida, L.; Silva, N.E.
Predictive Potential of Cmax Bioequivalence in Pilot Bioavailability/Bioequivalence Studies, through the Alternative ƒ2 Similarity Factor Method. Pharmaceutics 2023, 15, 2498.
https://doi.org/10.3390/pharmaceutics15102498
AMA Style
Henriques SC, Paixão P, Almeida L, Silva NE.
Predictive Potential of Cmax Bioequivalence in Pilot Bioavailability/Bioequivalence Studies, through the Alternative ƒ2 Similarity Factor Method. Pharmaceutics. 2023; 15(10):2498.
https://doi.org/10.3390/pharmaceutics15102498
Chicago/Turabian Style
Henriques, Sara Carolina, Paulo Paixão, Luis Almeida, and Nuno Elvas Silva.
2023. "Predictive Potential of Cmax Bioequivalence in Pilot Bioavailability/Bioequivalence Studies, through the Alternative ƒ2 Similarity Factor Method" Pharmaceutics 15, no. 10: 2498.
https://doi.org/10.3390/pharmaceutics15102498
APA Style
Henriques, S. C., Paixão, P., Almeida, L., & Silva, N. E.
(2023). Predictive Potential of Cmax Bioequivalence in Pilot Bioavailability/Bioequivalence Studies, through the Alternative ƒ2 Similarity Factor Method. Pharmaceutics, 15(10), 2498.
https://doi.org/10.3390/pharmaceutics15102498